EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The role of protein O-GlcNAcylation in diabetic cardiomyopathy

John C Chatham iD, Adam R Wende

Biochemical Society Transactions · 2024

DOI: 10.1042/bst20240262 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, 2024. Verfasst von John C Chatham und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular and Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, U.S.A. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Acetylglucosamine, Protein Processing, Post-Translational. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is well established that diabetes markedly increases the risk of multiple types of heart disease including heart failure. However, despite substantial improvements in the treatment of heart failure in recent decades the relative increased risk associated with diabetes remains unchanged. There is increasing appreciation of the importance of the post translational modification by O-linked-N-acetylglucosamine (O-GlcNAc) of serine and threonine residues on proteins in regulating cardiomyocyte function and mediating stress responses. In response to diabetes there is a sustained increase in cardiac O-GlcNAc levels, which has been attributed to many of the adverse effects of diabetes on the heart. Here we provide an overview of potential mechanisms by which increased cardiac O-GlcNAcylation contributes to the adverse effects on the heart and highlight some of the key gaps in our knowledge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic CardiomyopathiesAcetylglucosamineProtein Processing, Post-TranslationalHumansAnimalsGlycosylationMyocytes, Cardiac

Stichwörter der Autor:innen

O-GlcNAcdiabetesglycosylationmyocardium

Substanzen

Acetylglucosamine

Autor:innen und Institutionen

  • Division of Molecular and Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, U.S.A.

ORCID-Profile: John C Chatham

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Chatham, J. C., & Wende, A. R. (2024). The role of protein O-GlcNAcylation in diabetic cardiomyopathy. Biochemical Society Transactions. https://doi.org/10.1042/bst20240262

Vancouver

Chatham JC, Wende AR. The role of protein O-GlcNAcylation in diabetic cardiomyopathy. Biochemical Society Transactions. 2024. doi:10.1042/bst20240262

BibTeX
@article{Chatham2024,
  author = {Chatham, John C and Wende, Adam R},
  title = {The role of protein O-GlcNAcylation in diabetic cardiomyopathy},
  journal = {Biochemical Society Transactions},
  year = {2024},
  doi = {10.1042/bst20240262}
}
Kostenlos starten →